5Molecular medicine in thyroid surgery Chir Ital. 2008 Mar- Apr, 60(2) :165 -78.
6Koh JM, Kim ES, Ryu JS, et al. Effects of therapeutic doses of ^131 I in thyroid pap illary carcinoma patients with elevated thyroglobulin level and negative I^131 whole-body scan: comparative study. Clin Endocrinol 58 : 421 -427.
7Cohen MS, Moley JF. Surgical treatment of medullary thyroid carcinoma. J Intern Med ,2003,253 : 616 -626.
8Giammarile F,Hafdi Z, Boumaud C,et al. Is [ 18F] 222fluoro222 deoxy2d2glucose( FDG ) scintigraphy with non2dedicated positron emission tomography useful in the diagnostic management of suspected metastatic thyroid carcinoma in patients with no detectable radioiodine up take? Eur J Endocrinol,2003,149 : 293 - 300.
9Van Tol KM, Jager PL,de Vries EG, et al. Outcome in patients with differentiated thyroid cancer with negative diagnostic whole2body scanning and detectable stimulated thyroglobulin. Eur J Endocrinol,2003,148 : 589 - 596.
10Frasoldati A, PesentiM,Gallo M. Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma. Cancer, 2003,97 : 90 - 96.
